Nephrocare Health Services544647Board meeting scheduled
Board meeting on November 3, 2026 to consider and approve September quarter and half year results
Board meeting set for Tuesday, November 3, 2026.
- Board Meeting Date
- Tuesday, November 3, 2026
- Agenda
- Un-audited Standalone and Consolidated Financial Results for the quarter and half year ended September 30, 2026
- Trading Window Closed
- October 1, 2026 till November 5, 2026 (both days inclusive)
What the intimation says
- A meeting of the Board of Directors is scheduled to be held on Tuesday, November 3, 2026.
- The Board will, inter alia, consider and approve the Un-audited Standalone and Consolidated Financial Results of the Company for the quarter and half year ended September 30, 2026.
Why the trading window is shut
- The trading window for dealing in the Company's securities has been closed for all Designated Persons and their immediate relatives from October 1, 2026 till November 5, 2026 (both days inclusive).
- This follows the earlier intimation dated September 25, 2026.
- The closure covers the period running up to the Board meeting and a short window after it, so that people who may have access to unpublished price-sensitive information do not deal in the shares before the results are made public.
What to watch for
- The Board meeting is where the September quarter numbers are approved, and companies usually release the results around that date.
- The results are described as Un-audited, covering both Standalone and Consolidated financials, for the quarter as well as the half year ended September 30, 2026.
How to read this
- This is a routine scheduling intimation. It tells the market when the next set of financial results is expected to be taken up for approval.
- The intimation itself does not contain any financial figures, so the actual performance for the quarter and half year will only be known once the results are published.
Also from Nephrocare Health Services
Nephrocare Health Services Ltd shareholder buys 2.535% stake
28 Sep 2026
Source: BSE · 12 Oct 2026
Nothing here is a view, opinion or recommendation of ScoutQuest, its parent, directors or employees. ScoutQuest is a technology company: this page was assembled automatically from public sources using artificial intelligence, and may contain errors or omissions. Confirm everything against the original source before you act on it. Any use of this page is at your own risk, and neither ScoutQuest nor its parent, directors or employees accepts liability for it.